(0.16%) 5 477.90 points
(0.04%) 39 128 points
(0.49%) 17 805 points
(0.06%) $80.88
(-5.04%) $2.62
(-0.90%) $2 309.80
(-0.36%) $28.77
(2.90%) $1 015.00
(0.34%) $0.936
(0.63%) $10.67
(0.50%) $0.792
(0.86%) $88.24
-4.03% $ 39.80
Live Chart Being Loaded With Signals
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer...
Stats | |
---|---|
Volumen de hoy | 474 453 |
Volumen promedio | 863 790 |
Capitalización de mercado | 2.06B |
EPS | $-0.300 ( Q1 | 2024-05-08 ) |
Próxima fecha de ganancias | ( $0 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-33.17 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0590 (0.15%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-03 | Lichter Jay | Sell | 691 525 | Common Stock |
2024-06-03 | Lichter Jay | Sell | 677 279 | Common Stock |
2024-06-03 | Lichter Jay | Sell | 131 196 | Common Stock |
2024-06-03 | Reardon Tighe | Sell | 691 525 | Common Stock |
2024-06-03 | Reardon Tighe | Sell | 131 196 | Common Stock |
INSIDER POWER |
---|
-4.32 |
Last 96 transactions |
Buy: 12 578 246 | Sell: 9 922 298 |
Volumen Correlación
Janux Therapeutics, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Janux Therapeutics, Inc. Correlación - Moneda/Commodity
Janux Therapeutics, Inc. Finanzas
Annual | 2023 |
Ingresos: | $8.08M |
Beneficio Bruto: | $6.13M (75.81 %) |
EPS: | $-1.320 |
FY | 2023 |
Ingresos: | $8.08M |
Beneficio Bruto: | $6.13M (75.81 %) |
EPS: | $-1.320 |
FY | 2022 |
Ingresos: | $8.61M |
Beneficio Bruto: | $7.77M (90.23 %) |
EPS: | $-1.310 |
FY | 2021 |
Ingresos: | $3.64M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.794 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Janux Therapeutics, Inc.
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company\'s lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico